IT Consulting & Software company Mastek announced Q4FY25 results Revene: Rs 905.4 crore compared to Rs 779.7 crore during Q4FY24, change 15.8%. Net Profit: Rs 81.1 crore compared to Rs 94.4 crore during Q4FY24, change -14.1%. Operating EBITDA at Rs 138.8 crore, up 10.9% YoY. Healthcare vertical grew by 13.1% QoQ (USD terms). Proposed Final Dividend of Rs 16 per share cumulating to 460% for the year. Umang Nahata, Chief Executive Officer, Mastek, said: “We are pleased to report a steady performance in Q4FY25, delivering a revenue growth of 4.1% QoQ and 16.1% YoY in rupee terms. We closed FY25 with a strong annual revenue and PAT growth of 13.1% and 20.9% respectively in rupee terms, driven by disciplined execution across geographies and innovation across all service lines. We continue to enhance our Data & AI capabilities across verticals, with a focused go-tomarket approach targeting Fortune 1000 clients. Our 12-month order backlog grew by 7.1% QoQ, reflecting strong order book performance sustained by demand for our Digital Engineering, Cloud and Data & AI services. Our core business driven by UK & Europe and Oracle in US continues to grow strongly, particularly in the healthcare and commercial sectors. The UK healthcare and secured government services continue to show strong momentum, supported by the government’s 10- year modernization plan and increased investments in AI and data. With strong cash & cash equivalent of Rs 622.2 crore in Q4FY25, we remain committed to operational efficiency and margin improvement. The Board has recommended a final dividend of Rs 16 per share cumulating to 460% for the year [prior year 380%]. While macroeconomic uncertainties persist, our sharp execution focus and deep client partnerships positions Mastek for sustainable and profitable growth in FY26 and beyond.” Result PDF